Hem › Crohns sjukdom › South Carolina
Kliniska studier för Crohns sjukdom i South Carolina
11 studier för Crohns sjukdom söker deltagare vid platser i South Carolina.
Städer i South Carolina
Officiell studietext (engelska)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates, PA, Greenville
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Johns Hopkins University Gastroenterology and Hepatology-Site Number: 8400116, Columbia
- Biocentric Health Research Center-Site Number: 8400089, Columbia
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Palmetto Gastroenterology Clinical Research, Summerville
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 22 juni 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Medical University of South Carolina (MUSC), Charleston
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 15 jan. 2026 · NCT06257706Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.